Sentences with phrase «pharma industries said»

Not exact matches

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

«It just felt like there was this massive amount of waste,» she says, referring to the billions of dollars the pharma industry annually plunges into drug discovery, with diminishing results.

Experts say it's an unprecedented turnaround plan in the pharma industry.

Health Canada said that four companies have authorization to sell epinephrine auto - injectors — Kaleo Pharma, Taro Pharmaceutical Industries Ltd, Valeant Pharmaceuticals International Inc and Lincoln Medical Ltd — but none are currently marketing them in the country.

«Yeah, there are some folks [in the pharma industry] who may pursue this,» he said.

That deal cemented Actavis's rebirth as a branded and specialty pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&Pharma.»

The five companies Ohio sued were Purdue Pharma LP, Johnson & Johnson's Janssen Pharmaceuticals Inc unit, a unit of Endo International Plc, Teva Pharmaceutical Industries Ltd's Cephalon unit and Allergan Plc, DeWine said during a press conference in Columbus livestreamed online.

Meanwhile on Wednesday, President - elect Donald Trump shocked the drug industry at his first press conference since July, saying that pharma is «getting away with murder.»

When international travel buyers can't get visas to attend large U.S. pharma, heavy equipment or technology shows, «that doesn't just affect the travel industry,» Dow said.

Spencer said two counties in California and the City of Chicago have filed similar lawsuits in Federal court against drug companies Purdue Pharma L.P., The Purdue Frederick Company, Teva Pharmaceutical Industries LTD., Cephalon Inc., Johnson and Johnson, Janssen Pharmaceuticals, Endo Health Solutions Inc., and Actavis PLC..

Biotech and pharma are focusing more on products and less on the most promising research, say some experts, requiring industry - bound scientists to adapt.

«I think it is much easier for a person with a pharma or biotechnology background to get a job in the device industry than it is for a person with device experience to break into the pharma or biotech business,» says Ippolito, who spent more than 15 years in the biotechnology field before moving into the MD&D field.

«Because most of these products have been developed for a pretty well - resourced group of people in pharma and the chemical industry, the prices tend to be pretty big,» says Alan Wolf, who helped coordinate a recent pilot study designed to find an ELN suitable for university - wide adoption at the University of Wisconsin (UW), Madison.

«There are very good job opportunities for chemists, even with the pharma industry changing,» says Neil Champness, chair of chemical nanoscience at the University of Nottingham, UK.

The global economic downturn has kept many start - ups on the ground, says Derek Lowe, author of the pharma - industry blog In the Pipeline.

«It is rather obvious that the pharma industry is not interested in taking the driver's seat when we are dealing with commercially neglected drugs,» says Meheus.

McGlynn says the plan is to make and test a vaccine in India, which she says is «suitably placed with its talented scientific manpower, well - established pharma industry, and a huge commitment from the government.»

There is a need to interact with biotech and pharma, a need to understand intellectual property and patenting — all of this is really now part of the academic career,» says Alving, who adds «many individuals will have careers in academia, but they may have also spent some time in industry.

There are an increasing number of areas that industry is exiting, says Judy Slinn, a business historian who researches the pharma industry at Oxford Brookes University, UK.

Commenting on BTG's acquisition, Andrew Edge, head of corporate at Stephenson Harwood, said «We are delighted to have advised BTG on this significant acquisition and to be involved with BTG's continued progress as one of the British pharma and biotech industry's great success stories.»

This time, however, the source familiar with the patent coalition said that the pharma industry may stay out of the legislative debate — so long as the drug companies feel comfortable the measures are aimed at patent trolls and not pills.

«The pharma industry is on the sidelines because the bills are designed to not affect them,» said Levy.

She says she was referred to the site because it was so well known by friends in the industry as the best website for finding medical device, pharma and biotech sales jobs.